# FDA Inspection 1141831 - Daiichi Sankyo, Inc. - March 30, 2021

Source: https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-inc/8e6c8a62-1770-41e0-9b9a-05786ac5155f
Source feed: FDA_Inspections

> FDA Inspection 1141831 for Daiichi Sankyo, Inc. on March 30, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1141831
- Company Name: Daiichi Sankyo, Inc.
- Inspection Date: 2021-03-30
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1277224 - 2025-08-01](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-inc/63bf611c-4ad7-4991-8f19-7cdec7f9e84b)
- [FDA Inspection 1277224 - 2025-08-01](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-inc/e2183ff4-a455-43b1-b658-1b24df6b7d5b)
- [FDA Inspection 1192012 - 2022-11-30](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-inc/54334ea0-c055-49da-9918-4540cccc49f3)
- [FDA Inspection 1176597 - 2022-07-15](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-inc/075c0797-cf6f-40f7-8a33-92b3462a88c3)
- [FDA Inspection 1168866 - 2022-04-08](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-inc/0b1de5ad-f837-409f-a8d7-0c521064e60d)

Company: https://www.keypedia.com/companies/daiichi-sankyo-inc/fd789c74-6b2b-43fb-800d-326eceeb1aea

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c